Secondary |
Drug Use For Unknown Indication |
22.9% |
Dementia |
15.8% |
Constipation |
12.6% |
Pain |
9.9% |
Epilepsy |
7.1% |
Analgesic Therapy |
5.5% |
Muscle Spasms |
4.7% |
Depression |
3.6% |
Insomnia |
3.6% |
Gastritis |
3.2% |
Schizophrenia |
2.0% |
Bipolar Disorder |
1.6% |
Product Used For Unknown Indication |
1.6% |
Hypertension |
1.2% |
Analgesia |
0.8% |
Back Pain |
0.8% |
Benign Prostatic Hyperplasia |
0.8% |
Dysuria |
0.8% |
Fibromyalgia |
0.8% |
Fluid Replacement |
0.8% |
|
Pancytopenia |
19.5% |
Pyothorax |
17.1% |
Suicide Attempt |
9.8% |
Respiratory Failure |
7.3% |
Depressed Level Of Consciousness |
4.9% |
Platelet Count Decreased |
4.9% |
Suicidal Ideation |
4.9% |
Toxicity To Various Agents |
4.9% |
White Blood Cell Count Increased |
4.9% |
Cardiac Failure Acute |
2.4% |
Delirium |
2.4% |
Hypoxia |
2.4% |
Pancreatitis Acute |
2.4% |
Rhabdomyolysis |
2.4% |
Spina Bifida |
2.4% |
Subdural Hygroma |
2.4% |
Syncope |
2.4% |
White Blood Cell Count Decreased |
2.4% |
|
Concomitant |
Epilepsy |
15.9% |
Drug Use For Unknown Indication |
14.7% |
Depression |
8.2% |
Product Used For Unknown Indication |
8.2% |
Prophylaxis |
5.7% |
Pain |
5.5% |
Constipation |
4.9% |
Insomnia |
4.9% |
Hypertension |
4.1% |
Rheumatoid Arthritis |
3.9% |
Parkinson's Disease |
3.8% |
Bipolar I Disorder |
2.8% |
Schizophrenia |
2.6% |
Breast Cancer |
2.4% |
Cancer Pain |
2.4% |
Diabetes Mellitus |
2.4% |
Gastritis |
1.9% |
Schizophrenia, Paranoid Type |
1.9% |
Multiple Sclerosis |
1.8% |
Metastases To Bone |
1.7% |
|
White Blood Cell Count Increased |
12.9% |
White Blood Cell Count Decreased |
11.3% |
Pyrexia |
7.3% |
Myoclonus |
6.5% |
Rhabdomyolysis |
6.5% |
Pneumonia |
5.6% |
Suicide Attempt |
5.6% |
Growth Retardation |
4.0% |
Rash |
4.0% |
Tremor |
4.0% |
Death |
3.2% |
Gastrointestinal Necrosis |
3.2% |
Hepatic Function Abnormal |
3.2% |
Ileus |
3.2% |
Malaise |
3.2% |
Nasopharyngitis |
3.2% |
Osteomyelitis |
3.2% |
Osteonecrosis |
3.2% |
Platelet Count Decreased |
3.2% |
Pleural Effusion |
3.2% |
|